Progression of Hematopoietic Diseases in Shanghai, China

Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00365014

Enrollment

10757

Registered

2006-08-16

Start date

2003-08-31

Completion date

2009-12-31

Last updated

2013-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Diseases

Keywords

aplastic anemia, myelodysplastic syndromes, cytopenias, acute myeloid leukemia, myelodysplastic/myeloproliferative diseases, benzene poisoning

Brief summary

Detailed description

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility. The format for these studies is a set of clinical series superimposed on a case-control design that enables integration of detailed clinical and molecular characterizations of disease pathogenesis together with an evaluation of potential confounding and interacting factors within a structured statistical analysis of benzene exposure.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Men and women 18 years or older Diagnosis of hematologic abnormality

Exclusion criteria

Children Non hematologic diseases

Design outcomes

Primary

Measure	Time frame	Description
blood diseases presenting at Shanghai hospitals	hospital stay	characterization of people with blood diseases presenting at Shanghai hospitals

Countries

China

Outcome results